Frontiers in Oncology (Jun 2023)
ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
Abstract
This study investigates the relationship between ITGAL expression and immune infiltration, clinical prognosis, and specific types of T cells in melanoma tissue. The findings reveal the key role of ITGAL in melanoma and its potential mechanism of regulating tumor immune infiltrating cells, highlighting its potential as a diagnostic biomarker and therapeutic target for advanced melanoma.
Keywords